Ingevity (NGVT) Stock Price, News & Analysis

Company Overview

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment. Ingevity’s activated carbon solutions are designed to capture volatile organic compounds and other pollutants, while its composite materials offer enhanced strength and resistance for demanding environments. The company leverages proprietary technologies to customize sorbents, absorbents and filtration media to meet specific customer requirements.

Ingevity was formed in 2016 through the spin-off of the Specialty Chemicals division of MeadWestvaco Corporation, enabling the company to focus on innovation and growth in high-value chemistry markets. Since its inception, Ingevity has expanded its global presence with manufacturing facilities and sales offices across North America, Europe and Asia, serving a diversified customer base in more than 30 countries. The company employs approximately 1,900 people worldwide, working to deliver sustainable solutions derived from renewable and recycled raw materials.

Leadership at Ingevity is centered on President and Chief Executive Officer John C. Fortson, who has guided the company since its spin-off. Under his direction, Ingevity has pursued strategic investments in research and development, as well as targeted acquisitions to enhance its technology portfolio and expand its market reach. The company emphasizes sustainability in its operations, seeking to minimize environmental impact while delivering high-performance products to its global customers.

Key Stats

• Today's Range: $67.62 to $69.51
• 50-Day Range: $63.54 to $77.85
• 52-Week Range: $39.74 to $79.29
• Volume: 76,167 shs
• Average Volume: 303,219 shs
• Market Capitalization: $2.40 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $80.00
• Consensus Rating: Hold

Ingevity Stock Analysis - MarketRank™

Ingevity scored higher than 54% of companies evaluated by MarketBeat, and ranked 74th out of 180 stocks in the basic materials sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.0 / 5
• Analyst Rating: Hold

Consensus Rating

Ingevity has received a consensus rating of Hold. The company's average rating score is 2.20, and is based on no strong buy ratings, 2 buy ratings, 2 hold ratings, and 1 sell rating.

Upside Potential

Ingevity has a consensus price target of $80.00, representing about 15.8% upside from its current price of $69.06.

Amount of Analyst Coverage

Ingevity has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: 14.85%

Earnings Growth

Earnings for Ingevity are expected to grow by 14.85% in the coming year, from $5.05 to $5.80 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Ingevity is -19.46, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Ingevity is -19.46, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Ingevity has a P/B Ratio of 61.66. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.99% of the float of Ingevity has been sold short.

Short Interest Ratio / Days to Cover

Ingevity has a short interest ratio ("days to cover") of 3.74, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Ingevity has recently decreased by 7.66%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Ingevity does not currently pay a dividend.

Dividend Growth

Ingevity does not have a long track record of dividend growth.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

Search Interest

1 people have searched for NGVT on MarketBeat in the last 30 days.

Company Ownership

• Score: 0.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Ingevity insiders have not sold or bought any company stock.

Percentage Held by Insiders

0.88% of the stock of Ingevity is held by insiders.

Percentage Held by Institutions

91.59% of the stock of Ingevity is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 5/06/2026
• Today: 5/28/2026
• Next Earnings (Estimated): 8/03/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Basic Materials
• Industry: CHEM - SPECIALTY
• Sub-Industry: Chemicals
• Current Symbol: NYSE:NGVT
• Previous Symbol: NASDAQ:NGVT
• CIK: 1653477
• Web: www.ingevity.com
• Phone: (843) 740-2300
• Fax: 843-740-8165
• Employees: 1,500
• Year Founded: 2015

Price Target and Rating

• Average Price Target for Ingevity: $80.00
• High Price Target: $83.00
• Low Price Target: $75.00
• Potential Upside/Downside: +15.9%
• Consensus Rating: Hold
• Rating Score (0-4): 2.20
• Research Coverage: 5 Analysts

Profitability

• EPS (Trailing Twelve Months): ($3.55)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 13.67
• P/E Growth: N/A
• Net Income: -$167.10 million
• Net Margins: -10.55%
• Pretax Margin: -12.34%
• Return on Equity: 207.82%
• Return on Assets: 9.70%

Debt

• Debt-to-Equity Ratio: 27.83
• Current Ratio: 1.42
• Quick Ratio: 0.92

Sales & Book Value

• Annual Sales: $1.17 billion
• Price / Sales: 2.06
• Cash Flow: $12.37 per share
• Price / Cash Flow: 5.58
• Book Value: $1.12 per share
• Price / Book: 61.63

Miscellaneous

• Outstanding Shares: 34,770,000
• Free Float: 34,466,000
• Market Cap: $2.40 billion
• Optionable: Optionable
• Beta: 1.24